Tocilizumab Real-Life Human Factors (RLHFs) Validation Study
Public ClinicalTrials.gov record NCT02682823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tocilizumab Real-Life Human Factors Validation Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate RLHFs concerning administration of the tocilizumab autoinjector AI-1000 G2 in adults with rheumatoid arthritis (RA) who have been receiving subcutaneous (SC) tocilizumab using the commercially available prefilled syringe and needle safety device (PFS-NSD). The study will enroll participants with RA, a subset of whom will be assigned to perform self-injection with the AI-1000 G2. Enrolled caregivers (CGs) and healthcare professionals (HCPs) will administer the AI-1000 G2 injection to the remaining study participants.
Study identification
- NCT ID
- NCT02682823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2016
- Primary completion
- Jul 28, 2016
- Completion
- Jul 28, 2016
- Last update posted
- Apr 18, 2019
2016
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis and Rheuma | Mesa | Arizona | 85202 | — |
| Valerius Medical Group & Research Ctr of Greater Long Beach | Los Alamitos | California | 90720 | — |
| Pacific Arthritis Ctr Med Grp | Santa Maria | California | 93454 | — |
| Bluegrass Comm Research, Inc. | Lexington | Kentucky | 40515 | — |
| Oklahoma Center For Arthritis Therapy & Research | Tulsa | Oklahoma | 74104 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Advanced Rheumatology & Arthritis Research Center | Wexford | Pennsylvania | 15090 | — |
| Metroplex Clinical Research | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02682823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2019 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02682823 live on ClinicalTrials.gov.